
The small-cap company IN8bio promises to revolutionize oncology with cell therapies, including for the highly aggressive glioblastoma. While this treatment is a groundbreaking advancement that took place not long ago, its use remains limited. IN8bio seeks to change that. The cell revolution For decades, oncology relied on surgery, chemotherapy, and…